OBJECTIVE: To improve the production technology of prulifloxacin.
目的：改进普卢利沙星的生产工艺。
Objective: To optimize the best formulation technique of Prulifloxacin capsule.
目的：筛选普卢利沙星胶囊的最佳处方组成。
Objective: To establish a method for the test of impurities in prulifloxacin by HPLC.
目的：建立普卢利沙星有关物质检查的HPLC法。
Conclusions Prulifloxacin is as effective and safe as levofloxacin in the treatment of slight and moderate acute bacterial infections.
结论国产普卢利沙星注射液治疗轻、中度细菌感染疗效确切，安全性好。
Objective To evaluate the clinical efficacy and safety of prulifloxacin for the treatment of slight and moderate acute bacterial infections.
目的评价国产普卢利沙星治疗轻、中度急性细菌感染的临床疗效与安全性。
In those who could be tested for infection, 71 percent were well within 48 hours after getting prulifloxacin, compared to 33 percent of those given a placebo pill, he said.
他说，在受试的感染人群中，服用普卢利沙星的人中有71%在48小时内痊愈了，而安慰剂组仅有33%。
In those who could be tested for infection, 71 percent were well within 48 hours after getting prulifloxacin, compared to 33 percent of those given a placebo pill, he said.
他说，在受试的感染人群中，服用普卢利沙星的人中有71%在48小时内痊愈了，而安慰剂组仅有33%。
应用推荐